Our Services
Medical Information
Helpful Resources
Published on: 6/17/2026
Chronic dry eye relief requires more than over-the-counter artificial tears. While OTC drops offer brief comfort, they evaporate quickly, don't address underlying inflammation or meibomian gland dysfunction, and may worsen irritation due to preservatives. Eye care specialists recommend targeted prescription therapies, including anti-inflammatory drops like cyclosporine and lifitegrast, short-term steroids, autologous serum tears, and secretagogues. In-office procedures—such as punctal plugs and meibomian gland expression or thermal pulsation—can provide longer-lasting relief by treating root causes rather than masking symptoms.
Because chronic dry eye stems from many possible causes, identifying yours is the first step toward effective treatment. Take a free, instant, online symptom check to better understand what may be driving your symptoms and confidently navigate your next steps with your eye care provider.
Reviewed for medical accuracy: 06/17/2026
Chronic dry eyes affect millions of people worldwide. While over-the-counter (OTC) artificial tears can provide quick relief, they often fall short in addressing the underlying causes of persistent dryness. If you've been reaching for drop after drop with little long-term improvement, it's time to explore more comprehensive chronic dry eyes treatment options.
OTC artificial tears are designed to mimic your natural tear film and soothe irritation. However, they have limitations:
If you find yourself using drops hourly or waking up with gritty, burning eyes, consider this a sign that you need a deeper, more targeted chronic dry eyes treatment plan.
Chronic dry eye disease (DED) is a multifactorial condition. Key contributors include:
Addressing these root causes is essential for long-term relief and eye health.
If you experience any of the following, contact an eye care specialist:
Before scheduling an appointment, you can get personalized insights by taking a quick dry eye symptom assessment to help identify potential causes and determine if you need immediate care.
Eye doctors have a range of prescription therapies that go beyond lubrication:
Cyclosporine A (e.g., Restasis®, Cequa®)
• Mechanism: Reduces ocular surface inflammation and boosts tear production over weeks to months.
• Common side effects: Stinging, redness on instillation.
Lifitegrast 5% (Xiidra®)
• Mechanism: Blocks T-cell mediated inflammation.
• Onset: Some patients note improvement in 2–4 weeks.
• Side effects: Mild taste disturbance, temporary eye irritation.
Topical corticosteroids
• Short-term use for acute flares (e.g., loteprednol) to calm severe inflammation.
• Must be monitored by a doctor to avoid pressure spikes or cataract risk.
Eye doctors often combine prescription drops with procedural or device-based therapies to restore healthy tear film function:
Prescription therapies work best when paired with good eyelid hygiene and lifestyle adjustments:
Chronic dry eye disease is often a lifelong condition, but with the right mix of prescription treatments and self-care, most patients achieve significant relief and better quality of life.
While dry eyes rarely cause life-threatening issues, sudden vision loss, intense eye pain, or light sensitivity warrant an immediate doctor visit or emergency department evaluation.
If you suspect chronic dry eye disease, don't settle for temporary relief alone. Take charge of your eye health:
Remember, persistent dry eyes are treatable—working with your doctor is the best path to lasting comfort and clear vision. If you experience any serious or sudden changes in your eyesight or intense pain, seek medical attention right away.
(References)
* Jones LE, MacLennan CJ, Jones BDDJ. Dry Eye Disease: A Review of Current and Future Treatments. J Ocul Pharmacol Ther. 2021 Jul;37(5):269-281. doi: 10.1089/jop.2020.0102. Epub 2021 May 21. PMID: 34096706.
* Patel SM, Patel BK. The Evolving Landscape of Dry Eye Disease Management. Ophthalmol Ther. 2022 Dec;11(6):2049-2068. doi: 10.1007/s40123-022-00585-y. Epub 2022 Oct 20. PMID: 36263889; PMCID: PMC9736569.
* Ammar DA, Ammar GE. Current and Future Treatment Modalities for Dry Eye Disease. J Clin Med. 2023 Feb 1;12(3):1218. doi: 10.3390/jcm12031218. PMID: 36769493; PMCID: PMC9917531.
* Craig JP, Nichols KK, Cope T, et al. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017 Jul;15(3):276-302. doi: 10.1016/j.jts.2017.05.004. Epub 2017 May 17. PMID: 28781254.
* Ammar DA, Ammar DR. Emerging Treatments for Dry Eye Disease. Drugs. 2020 Feb;80(3):221-236. doi: 10.1007/s40265-020-01265-9. PMID: 31925692.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.